Key Drivers
- Gross Margin
- Thin Operations
- Rich Valuation
AIAI Summary
ATRC is no longer just a growth story—the stock now hinges on whether strong revenue and mid-70s gross margins can reliably translate into sustained operating profit and free cash flow, making execution and valuation the real swing factors until the company proves durable cash conversion.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Gross Margin
- •Thin Operations
- •Rich Valuation
ATRC has strong gross margins, solid liquidity, and manageable leverage, but thin operating profitability, volatile cash flow, and a rich valuation mean earnings consistency remains the key hurdle.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support rebound
- •Overhead resistance
ATRC drifted lower over the last month, but the bounce off $26.3-$26.7 shows buyers are defending support, and a reclaim of $28.8-$29.3 is needed to improve the trend.
Rebounded from a short-term low near $26.28 to $28.12, signaling near-term stabilization
Sentiment & News
Key News Insights:
- •Q1 Earnings Beat
- •Launch-Driven Growth
- •Competitive Pressure
AtriCure's Q1 beat and conference update point to solid operational momentum, with product launches and EnCompass adoption supporting its 2026 growth outlook despite competitive pressure.
This is modestly positive for ATRC, as disciplined execution and expanding product adoption appear to support further revenue growth
Similar Companies in Healthcare
Other companies in the same sector with AI ratings